tiprankstipranks
SI-Bone Inc (DE:2K3)
FRANKFURT:2K3
Germany Market
2K3
SI-Bone
RESEARCH TOOLSreports

SI-Bone (2K3) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

2K3 Analyst Ratings

Strong Buy
6Ratings
Strong Buy
6 Buy
0 Hold
0 Sell
Based on 6 analysts giving stock ratings to
SI-Bone
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

2K3 Stock 12 Month Forecast

Average Price Target

€19.78
▲(71.96% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for SI-Bone in the last 3 months. The average price target is €19.78 with a high forecast of €23.22 and a low forecast of €15.48. The average price target represents a 71.96% change from the last price of €11.50.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"9":"€9","24":"€24","12.75":"€12.75","16.5":"€16.5","20.25":"€20.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":23.21514243,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€23.22</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19.77586207,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€19.78</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.47676162,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€15.48</span>\n  </div></div>","useHTML":true}}],"tickPositions":[9,12.75,16.5,20.25,24],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12,12.862703263846154,13.725406527692307,14.58810979153846,15.450813055384614,16.313516319230768,17.17621958307692,18.03892284692308,18.90162611076923,19.764329374615386,20.627032638461536,21.489735902307693,22.352439166153847,{"y":23.21514243,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12,12.598143236153845,13.196286472307692,13.794429708461537,14.392572944615385,14.99071618076923,15.588859416923075,16.187002653076924,16.78514588923077,17.383289125384614,17.98143236153846,18.579575597692305,19.17771883384615,{"y":19.77586207,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12,12.26744320153846,12.534886403076923,12.802329604615384,13.069772806153846,13.337216007692307,13.60465920923077,13.87210241076923,14.139545612307693,14.406988813846153,14.674432015384616,14.941875216923076,15.209318418461539,{"y":15.47676162,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":11,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.9,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.3,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.3,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.7,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.7,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.7,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.8,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.1,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€23.22Average Price Target€19.78Lowest Price Target€15.48
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Needham Analyst forecast on DE:2K3
David Saxon
Needham
Needham
€23.22
Buy
101.87%
Upside
Reiterated
06/03/26
Analyst Reaffirms Buy on SI-Bone, Keeps $27 Price Target Amid Confidence in Growth and Profitability Outlook
Bank of America Securities Analyst forecast on DE:2K3
Travis Steed
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
05/13/26
Analysts Offer Insights on Healthcare Companies: Savara (NASDAQ: SVRA), Encompass Health (NYSE: EHC) and SI-Bone (NASDAQ: SIBN)
Truist Financial Analyst forecast on DE:2K3
Richard Newitter
Truist Financial
Truist Financial
€17.2→€15.48
Buy
34.58%
Upside
Reiterated
05/12/26
SI-Bone price target lowered to $18 from $20 at TruistSI-Bone price target lowered to $18 from $20 at Truist
TD Cowen Analyst forecast on DE:2K3
Mathew Blackman
TD Cowen
TD Cowen
€18.92→€15.48
Buy
34.58%
Upside
Reiterated
05/12/26
TD Cowen Reaffirms Their Buy Rating on SI-Bone (SIBN)
Canaccord Genuity Analyst forecast on DE:2K3
Caitlin Roberts
Canaccord Genuity
Canaccord Genuity
€23.22
Buy
101.87%
Upside
Reiterated
05/11/26
Analysts Are Bullish on These Healthcare Stocks: SI-Bone (SIBN), Perspective Therapeutics (CATX)
Piper Sandler Analyst forecast on DE:2K3
Matthew O'Brien
Piper Sandler
Piper Sandler
€21.5
Buy
86.92%
Upside
Reiterated
03/23/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Morgan Stanley Analyst forecast on DE:2K3
Patrick Wood
Morgan Stanley
Morgan Stanley
€19.78
Buy
71.96%
Upside
Reiterated
02/25/26
SI-Bone: Strengthening Fundamentals, Expanding Market Catalysts, and Accelerating Growth Support Buy Rating and $23 Target
Cantor Fitzgerald Analyst forecast on DE:2K3
Ross Osborn
Cantor Fitzgerald
Cantor Fitzgerald
€21.5
Buy
86.92%
Upside
Reiterated
08/11/25
Cantor Fitzgerald Keeps Their Buy Rating on SI-Bone (SIBN)
Jefferies Analyst forecast on DE:2K3
Matthew Taylor
Jefferies
Jefferies
€23.22→€24.07
Buy
109.35%
Upside
Reiterated
08/05/25
Jefferies Remains a Buy on SI-Bone (SIBN)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Needham Analyst forecast on DE:2K3
David Saxon
Needham
Needham
€23.22
Buy
101.87%
Upside
Reiterated
06/03/26
Analyst Reaffirms Buy on SI-Bone, Keeps $27 Price Target Amid Confidence in Growth and Profitability Outlook
Bank of America Securities Analyst forecast on DE:2K3
Travis Steed
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
05/13/26
Analysts Offer Insights on Healthcare Companies: Savara (NASDAQ: SVRA), Encompass Health (NYSE: EHC) and SI-Bone (NASDAQ: SIBN)
Truist Financial Analyst forecast on DE:2K3
Richard Newitter
Truist Financial
Truist Financial
€17.2→€15.48
Buy
34.58%
Upside
Reiterated
05/12/26
SI-Bone price target lowered to $18 from $20 at TruistSI-Bone price target lowered to $18 from $20 at Truist
TD Cowen Analyst forecast on DE:2K3
Mathew Blackman
TD Cowen
TD Cowen
€18.92→€15.48
Buy
34.58%
Upside
Reiterated
05/12/26
TD Cowen Reaffirms Their Buy Rating on SI-Bone (SIBN)
Canaccord Genuity Analyst forecast on DE:2K3
Caitlin Roberts
Canaccord Genuity
Canaccord Genuity
€23.22
Buy
101.87%
Upside
Reiterated
05/11/26
Analysts Are Bullish on These Healthcare Stocks: SI-Bone (SIBN), Perspective Therapeutics (CATX)
Piper Sandler Analyst forecast on DE:2K3
Matthew O'Brien
Piper Sandler
Piper Sandler
€21.5
Buy
86.92%
Upside
Reiterated
03/23/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Morgan Stanley Analyst forecast on DE:2K3
Patrick Wood
Morgan Stanley
Morgan Stanley
€19.78
Buy
71.96%
Upside
Reiterated
02/25/26
SI-Bone: Strengthening Fundamentals, Expanding Market Catalysts, and Accelerating Growth Support Buy Rating and $23 Target
Cantor Fitzgerald Analyst forecast on DE:2K3
Ross Osborn
Cantor Fitzgerald
Cantor Fitzgerald
€21.5
Buy
86.92%
Upside
Reiterated
08/11/25
Cantor Fitzgerald Keeps Their Buy Rating on SI-Bone (SIBN)
Jefferies Analyst forecast on DE:2K3
Matthew Taylor
Jefferies
Jefferies
€23.22→€24.07
Buy
109.35%
Upside
Reiterated
08/05/25
Jefferies Remains a Buy on SI-Bone (SIBN)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering SI-Bone

3 Months
Richard NewitterTruist Financial
Success Rate
7/15 ratings generated profit
47%
Average Return
+2.91%
Copying Richard Newitter's trades and holding each position for 3 Months would result in 46.67% of your transactions generating a profit, with an average return of +2.91% per trade.
1 Year
Richard NewitterTruist Financial
Success Rate
6/15 ratings generated profit
40%
Average Return
-2.15%
Copying Richard Newitter's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -2.15% per trade.
2 Years
Richard NewitterTruist Financial
Success Rate
4/15 ratings generated profit
27%
Average Return
-8.00%
Copying Richard Newitter's trades and holding each position for 2 Years would result in 26.67% of your transactions generating a profit, with an average return of -8.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

2K3 Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
5
6
5
5
5
Buy
10
6
4
4
4
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
15
12
9
9
9
In the current month, 2K3 has received 9 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2K3 average Analyst price target in the past 3 months is 19.78.
Each month's total comprises the sum of three months' worth of ratings.

2K3 Financial Forecast

2K3 Earnings Forecast

Next quarter’s earnings estimate for 2K3 is -€0.13 with a range of -€0.14 to -€0.11. The previous quarter’s EPS was -€0.09. 2K3 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 2K3 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 2K3 is -€0.13 with a range of -€0.14 to -€0.11. The previous quarter’s EPS was -€0.09. 2K3 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 2K3 has Performed in-line its overall industry.

2K3 Sales Forecast

Next quarter’s sales forecast for 2K3 is €47.13M with a range of €46.81M to €47.54M. The previous quarter’s sales results were €44.80M. 2K3 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 2K3 has Performed in-line its overall industry.
Next quarter’s sales forecast for 2K3 is €47.13M with a range of €46.81M to €47.54M. The previous quarter’s sales results were €44.80M. 2K3 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 2K3 has Performed in-line its overall industry.

2K3 Stock Forecast FAQ

What is DE:2K3’s average 12-month price target, according to analysts?
Based on analyst ratings, SI-Bone Inc’s 12-month average price target is 19.78.
    What is DE:2K3’s upside potential, based on the analysts’ average price target?
    SI-Bone Inc has 71.96% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is SI-Bone Inc a Buy, Sell or Hold?
          SI-Bone Inc has a consensus rating of Strong Buy, which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.
            What is SI-Bone Inc’s share price target?
            The average share price target for SI-Bone Inc is 19.78. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €23.22 ,and the lowest forecast is €15.48. The average share price target represents 71.96% Increase from the current price of €11.5.
              What do analysts say about SI-Bone Inc?
              SI-Bone Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
                How can I buy shares of SI-Bone Inc?
                To buy shares of DE:2K3, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.